Synchrocast: Understanding Brexit and its Impact on Patients

Synchrogenix's Darshan Kulkarni, Vice President, Regulatory Strategy and Policy, and Nirpal Virdee, Director, Client Services and Technology, talk about Brexit and its impact on patients. Listen in (or read the transcript) to learn more about Brexit, including the reasons behind the binary public referendum put to the United Kingdom's citizens back in 2016, and the outcome of the voting results. A ...

Read More

Brexit Impact on EudraCT Postings

The European Commission published a notice to stakeholders on September 6, reminding pharmaceutical companies of some unexpected impacts of Brexit in multiple areas, including the submission of clinical trial information to EudraCT. The submission of certain clinical trial information to the European Union (EU) database is a provision of an EU law which will no longer apply to the United Kingdom ( ...

Read More